Objective. Problems with sleep are common in patients with SSc and impact daily function. Little research, however, has examined factors associated with sleep disruption in SSc. Therefore, the objective of this study was to investigate socio-demographic and medical factors associated with sleep disruption in SSc.
Introduction
Patients with SSc experience numerous problems that contribute to reduced quality of life including fatigue, depression, pain, body image distress, sexual dysfunction and pruritus [1] . However, there is little research on sleep disturbances in SSc. Approximately 30% of the general population reports sleep disruption, including $50% of patients in clinical settings [2] . Sleep problems appear to be common in rheumatic disorders [3] , including SSc. A recent survey of 464 SSc patients, for instance, found that, of 69 symptoms queried, difficulty in sleeping was the fifth most frequently experienced (76%) and fourth most likely to impact daily function (59%) [4] . In the one study that has investigated the rate and correlates of sleep disturbances in SSc, 14 (53.6%) of 27 patients reported abnormally poor sleep, which was associated with gastroesophageal reflux disease and dyspnoea. In many rheumatic diseases [3] , pain is an important factor that affects sleep. In the general population, sleep problems are more common among people who are older, female, not married and have lower levels of education and income, as well as among cigarette smokers and those who consume high levels of alcohol and coffee [2] . The objective of this study was to investigate sociodemographic and clinical factors that may be associated with poor sleep in SSc. 
Patients and methods

Measures
Analyses of potential correlates of sleep disturbance included self-reported socio-demographic data (age, gender, race/ethnicity, education and marital status), SSc-related variables (duration, global severity, skin involvement, number of tender joints, breathing problems, number of gastrointestinal symptoms, pain and the presence of pruritus), smoking, alcohol consumption and symptoms of depression.
Sleep disturbance
Sleep disturbance was assessed with a 0100 mm VAS item, 'How much of a problem has sleeping been for you OVER THE PAST WEEK? (anchors Sleep is no problem = 0 and Sleep is a major problem = 100)'. A nearly identical item was used to study sleep disturbance in patients with RA [5] . Wolfe et al. [5] reported a mean (S.D.) on a similar sleep VAS of 35.9 (29.9) for 8676 patients with RA, and estimated a US population mean (S.D.) of 20.9 (2.6) based on data used in the development of the Short Form 36 Health Survey Questionnaire [6] .
Disease-related variables
SSc disease duration was determined as the time from onset of non-Raynaud's symptoms based on a physician clinical history. Skin involvement was assessed using the modified Rodnan skin score ranging from 0 to 51 [7] . Limited skin disease was defined as skin involvement distal to the elbows and knees with or without face involvement and diffuse disease as skin involvement of the proximal limbs and/or trunk [8] . The number of gastrointestinal symptoms was determined by patient report from a checklist of 14 symptoms that included poor appetite, difficulty in swallowing, acid reflux, nocturnal choking, heartburn, early satiety, abdominal bloating, nausea and vomiting, chronic constipation, chronic diarrhoea, antibiotics for bacterial overgrowth, greasy stools, faecal incontinence and parenteral nutrition. Shortness of breath ('In the past week how much have your breathing problems interfered with your daily activities?') was assessed by patients on a 010 numerical rating scale [9] . Tender joint count was recorded by study physicians using a 28-joint count [10] . The presence of pruritus was evaluated with a dichotomously scored item, 'I have or I have had in the past month itchiness in my skin, on most days' [11] . Current smoking was assessed by patient report. Alcohol consumption was assessed with the item, 'How many alcoholic drinks do you have per week?'
Symptoms of depression
The Center for Epidemiological Studies Depression Scale (CES-D) is a 20-item measure of depressive symptom severity that has been shown to have good reliability and convergent validity in SSc [12] . The frequency of occurrence of each symptom during the past week is rated on a 03 Likert-type scale ('rarely or none of the time' to 'most or all of the time') and total scores range from 0 to 60. Standard cut-offs are 516 for possible depression and 523 for probable depression [13] .
Pain was measured with an 11-point pain numerical rating scale (NRS; 'In the past week, how much pain have you had due to illness?') that has been used in prior studies of pain in SSc [14] , has strong validity and reliability across patient groups, and performs similarly to the pain VAS [15] . Continuous scores on the 11-point pain NRS range from 0 (no pain) to 10 (very severe pain). Categorical NRS scores of 14, 57 and 58 have been used to characterize mild, moderate and severe pain, respectively, in studies of cancer and musculoskeletal pain groups [16, 17] .
Statistical analysis
Pearson's correlation coefficients were used to assess bivariate associations with sleep VAS scores. Multivariate associations between socio-demographic variables (Step 1) and medical ( Step 2) variables with sleep VAS scores were assessed using hierarchical multiple linear regression. Model variables were selected a priori based on previous research on insomnia in the general population [2], rheumatic diseases [3] and SSc [3, 18] . To ensure that the sample size was adequate in relation to the numbers of predictors (e.g. 10 : 1) [19] , the basic model was limited to six variables, and other potential predictors were added one at a time on an exploratory basis, including total skin score, diffuse/limited status, pruritus, depressive symptoms, smoking and alcohol consumption. Analyses were conducted using PASW statistics version 18.0 (Chicago, IL, USA), and statistical tests were two-tailed with a P < 0.05 significance level.
Results
Sample characteristics
Of 70 patients included in the study, 86% (n = 60) were female, 96% (n = 65 of 68 with data) were white, 47% (n = 33) completed at least some post-secondary education and 70% (n = 49) were married or living as married. Mean (S.D.) age was 55.4 (11.6) years, $16% (n = 11) were smokers and 9% (n = 6) reported consuming more than seven alcoholic drinks/week. Mean (S.D.) duration since onset of non-Raynaud's symptoms was 12.3 (8.9) years, and since diagnosis of SSc was 9.3 (7.1) years. Approximately 37% (n = 26) had diffuse SSc ( Table 1) .
The mean (S.D.) pain NRS score was 3.9 (2.5); 90% (n = 63) of patients had at least mild pain (NRS 5 1), and 34% (n = 24) had moderate to severe pain (NRS 5 Mean (S.D.) sleep disturbance VAS score was 38.5 (29.9). Sleep VAS scores ranged from 0 to 100; 33% scored between 0 and 20 (n = 23), including 16% (n = 11) who scored 0; 27% between 21 and 40 (n = 19), 17% between 41 and 60 (n = 12), 9% between 61 and 80 (n = 6) and 14% between 81 and 100 (n = 10).
Correlates of sleep disturbance
Statistically significant bivariate correlates of sleep disturbance included marital status, smoking, gastrointestinal symptoms, breathing problems, pain and symptoms of depression (Table 1) . Only marital status ( = À0.24, P = 0.049) and pain ( = 0.50, P < 0.001) were significantly associated with sleep problems in the multivariate model ( Table 2) . Most of the 34% variance accounted for by predictor variables was explained by SSc disease variables, of which only pain was statistically significant.
None of the variables that were added individually to the basic model were statistically significant, including total skin score ( = 0.10, P = 0.362), diffuse/limited status ( = 0.09, P = 0.429), pruritus ( = 0.00, P = 0.977), smoking ( = 0.15, P = 0.198), alcohol consumption ( = 0.08, P = 0.464) and depressive symptoms ( = 0.12, P = 0.377). Depressive symptoms were correlated 
Discussion
The main finding of this study was that pain was strongly associated with sleep disturbance. Previous research has reported pain to be an important predictor of sleep problems in several rheumatic diseases, including RA [3, 5], and pain reported by patients with SSc is similar to levels of pain reported by patients with RA [14] . The importance of sleep problems in patients with SSc was illustrated by a recent survey, in which 464 Canadians with SSc rated sleep problems as one of the most frequent problems they experienced and one of the most likely to impact their ability to carry out daily activities [9] . Sleep problems had an even higher rated impact on the ability to carry out daily activities than important and common SSc symptoms, such as tender joints, muscle pain, skin tightening and pruritus. The mean sleep disturbance VAS score for patients with SSc in this study was 38.5, similar to the mean sleep VAS score reported by Wolfe et al. [5] for patients with RA (35.9) and substantially higher than a general population estimate (20.9) [5] . The robust association of pain with sleep problems in the current study supports the conclusion of Schieir et al. [14] that greater attention to pain, its consequences and its management is needed in SSc.
Breathing problems, number of gastrointestinal symptoms, smoking and symptoms of depression were associated with sleep scores in bivariate analyses, but not in the multivariate analysis. The fact that gastrointestinal symptoms and breathing problems, for instance, were associated with sleep on a bivariate basis, but not when pain was included, suggests that pain may be mediating the relationship between these common SSc symptoms and sleep. However, there are a number of limitations to the current study that suggest that it would be premature to draw firm conclusions about mediation processes or whether each potential predictor of sleep problems may be important for patients with SSc. Principally, the sample size in this study was small. Additionally, we used a single-item VAS measure of sleep rather than a validated multi-item questionnaire. The small sample size and the lack of a validated cut-off for the sleep VAS to identify patients with sleep problems did not allow us to dichotomously assess factors associated with clinically relevant sleep problems.
Future studies should consider using validated multiitem sleep questionnaires, as well as more sophisticated measurement approaches, including polysomnography and actigraphy. This study focused on factors related to sleep problems and assumed that pain leads to sleep problems. While the relationship between pain and sleep in this study was robust, some of this may be due to the influence of poor sleep on the experience of pain [20] .
An additional limitation to consider is that the results of this study were based on data from a convenience sample of patients with SSc. The median disease duration since the onset of non-Raynaud's symptoms was 10 years, suggesting a sample of patients with generally stable disease. Patients not cared for by a rheumatologist and patients with very severe SSc, who were too sick to participate, or who died earlier in their disease course were not included in the present study. This may have resulted in an over-representation of healthier patients in our SSc sample (survival cohort), and results may therefore not be generalizable to the full spectrum of SSc. On the other hand, it would not be inconceivable that patients with more severe disease could actually suffer from greater sleep problems, and thus our results may be For each step, individual variable parameters are shown, including raw regression coefficients (B) and their standard errors, as well as standardized regression coefficients (b) and P-values. In addition, overall model fit statistics and a P-value for the change in variance accounted for (ÁR) are shown for each step. Significant P-values are in bold.
conservative estimates of what would be found for the population of all SSc patients. In summary, sleep disturbance has been identified by patients as one of the most debilitating problems associated with SSc [4] . The level of sleep disturbance in SSc appears to be similar to levels reported in RA and strongly associated with pain. Additional studies that characterize the nature of sleep impairments and their relationships with pain in SSc are needed so that well-informed interventions to improve sleep for patients with SSc can be developed and tested [1] .
Rheumatology key messages
. Sleep disturbance scores are as high in SSc as in RA. . As in RA, pain is robustly associated with sleep disturbance in SSc.
